Tetracaine oral gel in patients treated with radiotherapy for head-and-neck cancer: Final results of a phase II study

Daniela Alterio, Barbara Alicja Jereczek-Fossa, Gabriele Fulvio Zuccotti, Maria Elena Leon, Emanuela Omodeo Sale, Marcella Pasetti, Tiziana Modena, Paola Perugini, Luigi Mariani, Roberto Orecchia

Research output: Contribution to journalArticle

Abstract

Purpose: We performed a phase II study to assess feasibility, pain relief, and toxicity of a tetracaine-based oral gel in the treatment of radiotherapy (RT)-induced mucositis. Methods and Materials: Fifty patients treated with RT for head-and-neck cancer with clinical evidence of acute oral mucositis of grade

Original languageEnglish
Pages (from-to)392-395
Number of pages4
JournalInternational Journal of Radiation Oncology Biology Physics
Volume64
Issue number2
DOIs
Publication statusPublished - Feb 1 2006

Keywords

  • Head-and-neck cancer
  • Mucositis
  • Radiation therapy
  • Tetracaine

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Radiation

Fingerprint Dive into the research topics of 'Tetracaine oral gel in patients treated with radiotherapy for head-and-neck cancer: Final results of a phase II study'. Together they form a unique fingerprint.

  • Cite this